CoDiagnostics, based in Salt Lake City, develops molecular tools for infectious disease detection, cancer screening, and agriculture, employing 155 staff. The company went public in July 2017 and is creating a portable diagnostic system for at-home use.
CODX has been in the news recently: Co-Diagnostics Inc. (CODX) experienced a significant decline in its share price, falling 28.26% to $0.46 in pre-market trading after an 80.76% gain the previous day. In contrast, other gainers reported a 15% increase in revenue this quarter, driven by strong sales and new customer acquisitions.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.